Azurity Pharmaceuticals Recalls One Lot of Zenzedi (dextroamphetamine sulfate) 30mg Tablets
February 05, 2024
On Jan. 25, 2024, Azurity Pharmaceuticals announced the recall of one lot of the stimulant medication Zenzedi® (dextroamphetamine sulfate tablets) 30mg to the consumer level after one bottle was found to contain the antihistamine carbinoxamine maleate.
Learn more